CIMG Inc. (CIMG): Nasdaq/NYSE listing notice — CIMG receives Nasdaq delist determination for failure to file periodic reports

CIMG Inc.

Received delist determination on June 27, 2025 for not filing Form 10-K (FY Sep 30, 2024) and Forms 10-Q.
Previously granted exception to file 10-K by June 13, 2025 and 10-Q by July 14, 2025 was not met.
Trading suspension on July 9, 2025 unless appeal requested by July 7, 2025; company intends to appeal.
Separate deficiency: failure to comply with the $2.5M stockholders' equity requirement also cited.
Company plans to file Form 10-K before July 7 and request a Nasdaq Hearings Panel hearing.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

CIMG Inc. received a nasdaq delisting notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: delisting notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

June 27, 2025, CIMG Inc. (Nasdaq: IMG) (the “Company”) received a delist determination letter from Nasdaq (“Nasdaq Delist Determination Letter”). On January 13, 2025, February 19, 2025 and May 19, 2025, Nasdaq notified the Company that it did not comply with Nasdaq’s filing requirements set forth in Listing Rule 5250(c)(1) (the “Rule”) because it had not filed its Form 10-K for the year ended September 30, 2024 (the “Initial Delinquent Filing”), and its Forms 10-Q for the periods ended December 31, 2024, and March 31, 2025 (the “Forms 10-Q”), respectively. As previously disclosed, Nasdaq had g

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

CIMG Inc. filing history →

Source: SEC EDGAR

accession 0001641172-25-017560

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.